Table 4

Association of Variables With Combined Endpoint

Univariable Analysisp Value
HR95% CIWald Test
Demographics
 Age, per 1 yr1.010.98–1.050.390.53
 Male0.740.33–1.660.530.46
Medical history
 Duration of symptoms, per 1 yr0.900.75–1.061.550.21
 History of hypertension0.410.15–1.093.200.059
 Atrial fibrillation1.540.64–6.781.840.31
 Complete LBBB1.070.45–2.540.020.89
 Hyperlipidemia0.220.03–1.632.190.14
 Diabetes mellitus0.040.00–7.201.470.23
 OSAS1.770.61–5.161.110.29
 Hyperthyroidism2.300.31–17.00.660.42
 Hyperthyroidism2.750.65–12.01.880.17
 Systemic disease0.940.22–3.970.0070.93
Echocardiography
 LVEF, per 1-U0.960.93–1.004.080.043
 LVEDD, per 1-U1.041.00–1.082.740.098
MOGE(S)
 (O)rgan involvement3.341.50–7.458.680.003
 (G)enetic or familial inheritance1.430.66–3.090.820.37
 (E)tiology known0.750.34–1.640.530.47
 Number of nongenetic etiologies1.170.74–1.850.440.51
 (G)+(E)2.381.06–5.354.410.036
 (S)tage of disease: NYHA≥32.431.13–5.235.120.024

CI = confidence interval; HR = hazard ratio; other abbreviations as in Table 1.

  • Death, heart transplantation, life-threatening arrhythmia.

  • Variables were considered significant at the 95% confidence interval (p < 0.05).

  • Significant interaction between covariates (p < 0.05).